Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06172322
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-11-24
Brief Title:
A Phase Ibâ…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive HER-2 Negative Breast Cancer
Sponsor:
Organization:
Nanjing Chia-tai Tianqing Pharmaceutical